What is Imlifidase and how does it help kidney transplants?

Imlifidase is a new drug available on the NHS that prevents organ rejection, leading to successful kidney transplants.

How long was Lorraine on dialysis before her transplant?

Lorraine was on dialysis for 13 years before receiving her successful kidney transplant.

How many times has the new kidney transplant drug been used in the UK?

The new drug, Imlifidase, has been used 8 times in the UK, including twice at Glenfield Hospital in Leicester.

Home / Health / 13 Years on Dialysis, Now a New Life with Wonder Drug

13 Years on Dialysis, Now a New Life with Wonder Drug

28 Jan

•

Summary

A new drug, Imlifidase, prevents organ rejection after kidney transplants.
Lorraine received a successful kidney transplant after 13 years on dialysis.
The drug is now available on the NHS and has been used 8 times in the UK.

13 Years on Dialysis, Now a New Life with Wonder Drug

A revolutionary new drug, Imlifidase, is offering new hope for kidney transplant patients. This medication has successfully prevented organ rejection, enabling successful transplants for individuals who previously faced prolonged periods on dialysis.

Lorraine is one such patient whose life has been profoundly changed by Imlifidase. After 13 years dependent on dialysis, her body accepted a new kidney without rejection, marking a pivotal moment in her medical journey. This drug, now accessible through the NHS, has been utilized eight times across the UK.

Glenfield Hospital in Leicester has been at the forefront of administering this innovative treatment, performing two of the eight successful transplant procedures. The availability of Imlifidase represents a significant advancement in transplant medicine, offering a brighter future for many.